AlphAIAlphAI — Financial news for AI agents
investing.comOCT 12 min read$CALM

Cal-Maine Foods earnings analysis: questions answered and next catalysts

Cal-Maine Foods (CALM) reported Q1 FY2027 earnings below estimates, with revenue down 41.5% YoY and a net loss of $58.6M. Management cited oversupply in the conventional egg market and rising costs. The stock fell 3.5% premarket. Next catalysts include Q2 earnings and prepared foods capacity expansion.

Original reporting
investing.com
Published Oct 1, 2026, 6:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 7:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CALM
Bearish
high confidence
Mentioned
$CALM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CALMBearishHigh
01

Why it matters

The miss underscores supply oversupply and cost pressures, suggesting near‑term downside but possible medium‑term recovery.

02

Market read

Earnings miss drives immediate price decline and may influence related agribusiness stocks.

03

What to watch

Potential upside from lower commodity exposure and upcoming capacity expansion in FY2028.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Cal-Maine Foods is the largest U.S. egg producer; its earnings are a bellwether for the commodity egg market.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine Foods reported FY2027 Q1 earnings miss: EPS -$1.26 vs -$0.47 estimate and revenue $539.6M vs $587.8M.

Expected impact

likely pressure as the market prices in the earnings miss and lowered guidance.

Evidence & confidence

The company posted a large loss and missed both EPS and revenue expectations, prompting a 3.5% pre‑market decline.

Market effects

Sector

Egg and prepared‑foods sector may see broader scrutiny as supply‑driven pressures emerge.

Regional

U.S. agribusiness stocks could face short‑term weakness.

Global

Limited to U.S. consumer‑staples and agricultural commodity markets.

Counterpoint

What could challenge this read

If the prepared‑foods ramp succeeds, the miss could be temporary and the stock may be undervalued.

Key entities

  • Company
    Cal-Maine Foods

    U.S. egg producer (ticker CALM).

Read at source← All news

Also covered by

2 outlets

Related articles

OCT 1
$CALMMed

Cal-Maine Foods (CALM) Q1 2027 Earnings Call Transcript

Cal-Maine Foods (CALM) reported Q1 2027 net sales of $539.6M, down 41.5% YoY, and a net loss of $58.6M. The decline was driven by lower conventional shell egg prices due to industry supply imbalances. Specialty shell egg and prepared foods sales also decreased. The company is investing in capacity expansion for prepared foods and remains debt-free with $767.6M in cash. Management expects future earnings growth from diversification and supply rebalancing.

fool.com3 min
SEP 30
$CALMMed

Why Cal-Maine Foods Stock Dipped on Wednesday

Cal-Maine Foods reported Q1 2027 revenue of $539.6M, down 42% YoY, and a GAAP net loss of $58.6M ($1.26 per share). Both figures missed analyst estimates. The company suspended its dividend. Specialty eggs and prepared foods were profitable, but the core conventional egg business posted a loss of over $71M. The stock fell 0.7% on the news.

fool.com2 min
SEP 30
$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

cnbc.com2 min
SEP 30
$CALMMedAI 8/10

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

qz.com2 min
SEP 30
$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.

financialcontent.com2 min